BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 18752772)

  • 1. New thoughts about estrogen therapy from the Women's Health Initiative.
    Ko MG
    Curr Osteoporos Rep; 2008 Sep; 6(3):108-13. PubMed ID: 18752772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perspectives on the Women's Health Initiative trial of hormone replacement therapy.
    Grimes DA; Lobo RA
    Obstet Gynecol; 2002 Dec; 100(6):1344-53. PubMed ID: 12468183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Menopause and hormone replacement therapy.
    Johnson SR
    Med Clin North Am; 1998 Mar; 82(2):297-320. PubMed ID: 9531927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone replacement therapy in the post-Women's Health Initiative era. Report a a meeting held in Funchal, Madeira, February 24-25, 2003.
    Burger H
    Climacteric; 2003 May; 6 Suppl 1():11-36. PubMed ID: 12945798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relevance of the Women's Health Initiative results on combined hormone replacement therapy in clinical practice.
    Lemay A
    J Obstet Gynaecol Can; 2002 Sep; 24(9):711-5. PubMed ID: 12360366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The SOGC statement on the WHI report on estrogen and progestin use in postmenopausal women.
    Blake JM; Collins JA; Reid RL; Fedorkow DM; Lalonde AB; Christilaw J; Fortier M; Fortin C; Jolly EE; Lemay A; O'Grady T; Smith TE; Cooper J; Maxted JM; O'Grady K; Turek MA;
    J Obstet Gynaecol Can; 2002 Oct; 24(10):783-90, 793-802. PubMed ID: 12399806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolving issues in the clinical and managed care settings on the management of menopause following the women's health initiative.
    Lukes A
    J Manag Care Pharm; 2008 Apr; 14(3 Suppl):7-13. PubMed ID: 18439061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormone replacement therapy in postmenopausal women.
    Prelevic GM; Kocjan T; Markou A
    Minerva Endocrinol; 2005 Mar; 30(1):27-36. PubMed ID: 15877011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical study of the month. Benefit/risk balance of postmenopausal estrogen-progestin treatment in peril in the Women's Health Initiative study: practical attitude of the clinician].
    Gaspard U; van den Brûle F; Pintiaux A; Foidart JM
    Rev Med Liege; 2002 Aug; 57(8):556-62. PubMed ID: 12405030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of hormone replacement therapy in postmenopausal women with type 2 diabetes.
    Cefalu WT
    J Womens Health Gend Based Med; 2001 Apr; 10(3):241-55. PubMed ID: 11389784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefits of hormone replacement therapy in postmenopausal women.
    Canderelli R; Leccesse LA; Miller NL; Unruh Davidson J
    J Am Acad Nurse Pract; 2007 Dec; 19(12):635-41. PubMed ID: 18042129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group.
    Control Clin Trials; 1998 Feb; 19(1):61-109. PubMed ID: 9492970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of hormone replacement therapy by postmenopausal women after publication of the Women's Health Initiative Trial.
    Ness J; Aronow WS; Newkirk E; McDanel D
    J Gerontol A Biol Sci Med Sci; 2005 Apr; 60(4):460-2. PubMed ID: 15933383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The evolving role of oral hormonal therapies and review of conjugated estrogens/bazedoxifene for the management of menopausal symptoms.
    Parish SJ; Gillespie JA
    Postgrad Med; 2017 Apr; 129(3):340-351. PubMed ID: 28132583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Women's Health Initiative trial and related studies: 10 years later: a clinician's view.
    Gurney EP; Nachtigall MJ; Nachtigall LE; Naftolin F
    J Steroid Biochem Mol Biol; 2014 Jul; 142():4-11. PubMed ID: 24172877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hormone replacement therapy in peri- and postmenopause].
    Henes M; Hübner S
    Internist (Berl); 2020 Jun; 61(6):558-564. PubMed ID: 32333087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A personal initiative for women's health: to challenge the Women's Health Initiative.
    Genazzani AR; Gambacciani M
    Gynecol Endocrinol; 2002 Aug; 16(4):255-7. PubMed ID: 12396552
    [No Abstract]   [Full Text] [Related]  

  • 18. Attitudes of Korean clinicians to postmenopausal hormone therapy after the Women's Health Initiative study.
    Kang BM; Kim MR; Park HM; Yoon BK; Lee BS; Chung HW; Cho SH; Choi H; Kim JG
    Menopause; 2006; 13(1):125-9. PubMed ID: 16607108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Menopausal hormone therapy: currently no evidence for cardiac protection.
    Wenger NK
    Pediatr Blood Cancer; 2005 Jun; 44(7):625-9. PubMed ID: 15747336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. After the Women's Health Initiative: Postmenopausal women's experiences with discontinuing estrogen replacement therapy.
    Haskell SG
    J Womens Health (Larchmt); 2004 May; 13(4):438-42. PubMed ID: 15186661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.